Taiwan
· Delayed Price · Currency is TWD Synmosa Biopharma Statistics
Total Valuation
TPEX:4114 has a market cap or net worth of TWD 16.73 billion. The enterprise value is 17.39 billion.
| Market Cap | 16.73B |
| Enterprise Value | 17.39B |
Important Dates
The next estimated earnings date is Monday, August 11, 2025.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | Jul 11, 2025 |
Share Statistics
TPEX:4114 has 455.25 million shares outstanding. The number of shares has increased by 2.50% in one year.
| Current Share Class | 455.25M |
| Shares Outstanding | 455.25M |
| Shares Change (YoY) | +2.50% |
| Shares Change (QoQ) | +3.08% |
| Owned by Insiders (%) | 10.43% |
| Owned by Institutions (%) | 4.39% |
| Float | 356.13M |
Valuation Ratios
The trailing PE ratio is 21.98.
| PE Ratio | 21.98 |
| Forward PE | n/a |
| PS Ratio | 2.93 |
| PB Ratio | 1.79 |
| P/TBV Ratio | 2.17 |
| P/FCF Ratio | 26.77 |
| P/OCF Ratio | 19.35 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.94, with an EV/FCF ratio of 27.82.
| EV / Earnings | 24.49 |
| EV / Sales | 3.04 |
| EV / EBITDA | 15.94 |
| EV / EBIT | 22.95 |
| EV / FCF | 27.82 |
Financial Position
The company has a current ratio of 2.52, with a Debt / Equity ratio of 0.28.
| Current Ratio | 2.52 |
| Quick Ratio | 1.75 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 2.41 |
| Debt / FCF | 4.25 |
| Interest Coverage | 13.10 |
Financial Efficiency
Return on equity (ROE) is 5.55% and return on invested capital (ROIC) is 4.26%.
| Return on Equity (ROE) | 5.55% |
| Return on Assets (ROA) | 3.75% |
| Return on Invested Capital (ROIC) | 4.26% |
| Return on Capital Employed (ROCE) | 6.92% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.45 |
| Inventory Turnover | 1.81 |
Taxes
In the past 12 months, TPEX:4114 has paid 185.63 million in taxes.
| Income Tax | 185.63M |
| Effective Tax Rate | 27.80% |
Stock Price Statistics
The stock price has decreased by -2.67% in the last 52 weeks. The beta is -0.06, so TPEX:4114's price volatility has been lower than the market average.
| Beta (5Y) | -0.06 |
| 52-Week Price Change | -2.67% |
| 50-Day Moving Average | 34.25 |
| 200-Day Moving Average | 34.49 |
| Relative Strength Index (RSI) | 69.89 |
| Average Volume (20 Days) | 1,276,101 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4114 had revenue of TWD 5.72 billion and earned 710.08 million in profits. Earnings per share was 1.67.
| Revenue | 5.72B |
| Gross Profit | 2.47B |
| Operating Income | 771.26M |
| Pretax Income | 667.62M |
| Net Income | 710.08M |
| EBITDA | 1.10B |
| EBIT | 771.26M |
| Earnings Per Share (EPS) | 1.67 |
Balance Sheet
The company has 3.13 billion in cash and 2.66 billion in debt, giving a net cash position of 477.77 million or 1.05 per share.
| Cash & Cash Equivalents | 3.13B |
| Total Debt | 2.66B |
| Net Cash | 477.77M |
| Net Cash Per Share | 1.05 |
| Equity (Book Value) | 9.33B |
| Book Value Per Share | 17.99 |
| Working Capital | 3.87B |
Cash Flow
In the last 12 months, operating cash flow was 864.79 million and capital expenditures -239.76 million, giving a free cash flow of 625.03 million.
| Operating Cash Flow | 864.79M |
| Capital Expenditures | -239.76M |
| Free Cash Flow | 625.03M |
| FCF Per Share | 1.37 |
Margins
Gross margin is 43.25%, with operating and profit margins of 13.49% and 12.42%.
| Gross Margin | 43.25% |
| Operating Margin | 13.49% |
| Pretax Margin | 11.68% |
| Profit Margin | 12.42% |
| EBITDA Margin | 19.31% |
| EBIT Margin | 13.49% |
| FCF Margin | 10.94% |
Dividends & Yields
This stock pays an annual dividend of 0.60, which amounts to a dividend yield of 1.63%.
| Dividend Per Share | 0.60 |
| Dividend Yield | 1.63% |
| Dividend Growth (YoY) | -0.15% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 32.21% |
| Buyback Yield | -2.50% |
| Shareholder Yield | -0.86% |
| Earnings Yield | 4.24% |
| FCF Yield | 3.74% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 9, 2024. It was a forward split with a ratio of 1.1.
| Last Split Date | Aug 9, 2024 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
TPEX:4114 has an Altman Z-Score of 3.11 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.11 |
| Piotroski F-Score | 7 |